Maria Martell
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Optimization of Statin-Loaded Delivery Nanoparticles for Treating Chronic Liver Diseases by Targeting Liver Sinusoidal Endothelial Cells.
Journal: Pharmaceutics
Published: September 14, 2023
Proteomic Analysis of Dysfunctional Liver Sinusoidal Endothelial Cells Reveals Substantial Differences in Most Common Experimental Models of Chronic Liver Diseases.
Journal: International journal of molecular sciences
Published: June 07, 2023
Liver steatosis induces portal hypertension regardless of fibrosis in patients with NAFLD: A proof of concept case report.
Journal: JHEP reports : innovation in hepatology
Published: August 15, 2022
Synergic effect of atorvastatin and ambrisentan on sinusoidal and hemodynamic alterations in a rat model of NASH.
Journal: Disease models & mechanisms
Published: December 16, 2020
Steatosis as main determinant of portal hypertension through a restriction of hepatic sinusoidal area in a dietary rat nash model.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: April 17, 2020
Simvastatin-loaded polymeric micelles are more effective and less toxic than conventional statins in a pre-clinical model of advanced chronic liver disease.
Journal: Nanomedicine : nanotechnology, biology, and medicine
Published: January 23, 2020
Morphofunctional Changes After Sleeve Gastrectomy and Very Low Calorie Diet in an Animal Model of Non-Alcoholic Fatty Liver Disease.
Journal: Obesity surgery
Published: July 16, 2017
Restoration of a healthy intestinal microbiota normalizes portal hypertension in a rat model of nonalcoholic steatohepatitis.
Journal: Hepatology (Baltimore, Md.)
Published: July 06, 2017
Last Updated: 09/26/2026